Active, Not Recruiting
Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer
NCT06253520
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +41 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States